FORBES FEATURES MEDICAL MARIJUANA, INC. PORTFOLIO COMPANY KANNALIFE IN ARTICLE ON NFL AND CONCUSSION-RELATED DISEASE CTE
Article Explains How Cannabis Could Be the “Holy Grail” of Neurological MedicineMedical Marijuana, Inc. (OTC: MJNA) announced today that its portfolio company Kannalife Sciences, Inc. (“Kannalife”) was the focus of a Forbes article that discussed Kannalife’s role in developing a pharmaceutical treatment for the degenerative brain disorder Chronic Traumatic Encephalopathy (CTE), a